Health News
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Generic HIV Drugs May Be Less Effective

Generic HIV Drugs May Be Less Effective
1/15/2013 10:20 AM ET

Generic HIV/AIDS medications are less expensive but may also be less effective, says a new study from researchers at Massachusetts General Hospital. In an extensive trial, the researchers administered a generic replacement for the standard treatment Atripla.

It takes three generic drugs, tenofovir (Viread), emtricitabine (Emtriva) and efavirenz (Sustiva), to replace the medicine found in one Atripla pill. Each patient in the trial took all three medications and researchers found, on average, those taking the premium pill saved roughly 4.4 months of life.

The trade off, however, is that the generic drugs saved roughly $42,500 per patient:

"This is a trade-off that many of us will find emotionally difficult, and perhaps even ethically impossible, to recommend," said lead researcher Dr Rochelle Walensky.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Health News

comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.